Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection

by Mario Peribañez-Gonzalez, Mariliza Henrique daSilva, Fernando Crivelenti Vilar, Ana Catharina Seixas-Santos Nastri, Paulo Abrão Ferreira, Roberto Focaccia, Maria Cássia Mendes Correa
Published 2013-03-01

Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever cases

by Luciana Vilas Boas Casadio, Ana Paula Moreira Salles, Fernanda de Mello Malta, Gabriel Fialkovitz Leite, Yeh-Li Ho, Michele Soares Gomes-Gouvêa, Luiz Marcelo Sá Malbouisson, Anna S Levin, Raymundo Soares de Azevedo Neto, Flair José Carrilho, Ana Catharina Seixas Santos Nastri, João Renato Rebello Pinho
Published 2019-05-01

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

by Aline Vitali Grando, Paulo Roberto Abrão Ferreira, Mário Guimarães Pessôa, Daniel Ferraz de Campos Mazo, Carlos Eduardo Brandão-Mello, Tânia Reuter, Ana de Lourdes Candolo Martinelli, Mário Peribanez Gonzalez, Ana Catharina Seixas-Santos Nastri, Aléia Faustina Campos, Max Igor Banks Ferreira Lopes, José David Urbaez Brito, Maria Cássia Mendes-Corrêa
Published 2017-11-01